You might find that your usual cravings for high-sugar or high-fat snacks begin to dim as the medication interacts with the reward centers of your brain
Zepbound (tirzepatide) is now FDA-approved for obstructive sleep apnea, which has opened a coverage pathway for some patients whose plans exclude weight-loss treatment
GLP-1 analogues delay gastric emptying ( When initiating GLP-1based therapy, clinicians should adhere to the principle of do no harm , particularly during the early phases of treatment when gastrointestinal adverse effects are most likely to emerge ( Potentially the easiest way to prevent nausea and vomiting is by starting at a low dose ( In most cases of Grade 1 or 2 nausea, maintaining the current dose for one to two additional dosing intervals is sufficient to allow symptom resolution
A hybrid revenue model works best for most medical weight loss programs
The drug works through the receptors it claims to work through, and it stops working when you take those receptors away
doi:10.1093/humupd/dmz019 Merhi Z, Karekar M, Mouanness M
